Schrodinger Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), HilleVax, Inc (HLVX) and Schrodinger (SDGR)
Schrodinger Analyst Ratings
Maintaining Neutral: Assessing Schrodinger's Mixed Q1 Performance and Future Outlook
Schrodinger Analyst Ratings
Maintained Buy Rating on Schrodinger: Navigating Short-Term Hurdles With Long-Term Catalysts in Sight
Craig-Hallum Remains a Buy on Schrodinger (SDGR)
R1 RCM, Health Catalyst Downgraded as KeyBanc Reviews Health-tech Space
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA) and Schrodinger (SDGR)
Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)
Schrodinger Analyst Ratings
Critical Insights From Schrodinger Analyst Ratings: What You Need To Know
Schrodinger Analyst Ratings
Buy Rating Affirmed for Schrodinger Amidst Robust Software Business and Promising Clinical Milestones
Schrodinger: A Neutral Rating With Revised Price Objective Amidst Growth Uncertainties
Maintaining a Neutral Stance on Schrodinger Amidst Growth and Uncertainties
Analysts' Opinions Are Mixed on These Healthcare Stocks: Schrodinger (SDGR), Editas Medicine (EDIT) and MacroGenics (MGNX)
Analysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH) and Schrodinger (SDGR)
Craig-Hallum Sticks to Their Buy Rating for Schrodinger (SDGR)
Schrodinger Analyst Ratings